Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Kallikrein-1 (Protein)

Uniprotkb:P06870

Id:0ca58a1a-42a7-5268-b3c0-ddfe456356c4

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Kallikrein-1 's neighborhood in the knowledge graph.

Results found

Linked to

	Label	Description
	4,4'-(pentane-1,5-diylbis(oxy))bis(3,5-dibromobenzimidamide) bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	6-Phenethyl-8-(pyrimidin-2-ylamino)-naphthalene-2-carboxamidine bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9174974, Example 1 bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-(4-carbamimidoylphenyl)-3-ethoxy-2-hydroxybenzamide hydrochloride bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(R)-2-(1-Amino-isoquinolin-6-ylamino)-7-(propane-2-sulfonyl)-4,11-diazatricyclo[14.2.2.16,10]henicosa-1(19),6,8,10(21),16(20),17-hexaene-3,12-dione bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-(1-Amino-isoquinolin-6-ylamino)-13-oxa-4,11-diaza-tricyclo[14.2.2.1(6,10)]henicosa-1(19),6(21),7,9,16(20),17-hexaene-3,12-dione bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(R)-11-(1-Amino-4-fluoro-isoquinolin-6-ylamino)-16-cyclopropane sulfonyl-7-(2,2-difluoro-ethoxy)-13-methyl-2,13-diaza-tricyclo[13.3.1.1(6,10)]icosa-1(19),6,8,10(20),15,17-hexaene-3,12-dione bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9174974, Example 31 bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(3S,6S,9S,12S,15S,18S,21S,24R,29R,34aS)-29-amino-3-(4-aminobutyl)-9,21-dibenzyl-12-((1-carbamimidoylpiperidin-4-yl)methyl)-6-(3-guanidinopropyl)-18-isobutyl-15-methyl-1,4,7,10,13,16,19,22,30-nonaoxodotriacontahydropyrrolo[2,1-b<sub>1</sub>][1,2,5,8,11,14,17,20,23,26,29]dithianonaazacyclodotriacontine-24-carboxylic acid bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9174974, Example 14 bioactivity Kallikrein-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

4,4'-(pentane-1,5-diylbis(oxy))bis(3,5-dibromobenzimidamide) bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

6-Phenethyl-8-(pyrimidin-2-ylamino)-naphthalene-2-carboxamidine bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9174974, Example 1 bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

N-(4-carbamimidoylphenyl)-3-ethoxy-2-hydroxybenzamide hydrochloride bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(R)-2-(1-Amino-isoquinolin-6-ylamino)-7-(propane-2-sulfonyl)-4,11-diazatricyclo[14.2.2.16,10]henicosa-1(19),6,8,10(21),16(20),17-hexaene-3,12-dione bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

2-(1-Amino-isoquinolin-6-ylamino)-13-oxa-4,11-diaza-tricyclo[14.2.2.1(6,10)]henicosa-1(19),6(21),7,9,16(20),17-hexaene-3,12-dione bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(R)-11-(1-Amino-4-fluoro-isoquinolin-6-ylamino)-16-cyclopropane sulfonyl-7-(2,2-difluoro-ethoxy)-13-methyl-2,13-diaza-tricyclo[13.3.1.1(6,10)]icosa-1(19),6,8,10(20),15,17-hexaene-3,12-dione bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9174974, Example 31 bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(3S,6S,9S,12S,15S,18S,21S,24R,29R,34aS)-29-amino-3-(4-aminobutyl)-9,21-dibenzyl-12-((1-carbamimidoylpiperidin-4-yl)methyl)-6-(3-guanidinopropyl)-18-isobutyl-15-methyl-1,4,7,10,13,16,19,22,30-nonaoxodotriacontahydropyrrolo[2,1-b<sub>1</sub>][1,2,5,8,11,14,17,20,23,26,29]dithianonaazacyclodotriacontine-24-carboxylic acid bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9174974, Example 14 bioactivity Kallikrein-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.